Show simple item record

dc.contributor.authorPrentice, David
dc.date2021-11-25T13:34:59.000
dc.date.accessioned2021-11-26T11:51:40Z
dc.date.available2021-11-26T11:51:40Z
dc.date.issued2013-02-23T11:50:28-08:00
dc.identifieryjhple/vol2/iss1/12
dc.identifier.contextkey3770783
dc.identifier.urihttp://hdl.handle.net/20.500.13051/5970
dc.description.abstractThe use of federal funds for human embryonic stem cell research is unwarranted. Beyond the substantial legal and ethical dilemmas inherent in such research, the scientific evidence shows that adult stem cells have vast biomedical potential to cure conditions such as diabetes, Parkinson's disease, heart disease, and other degenerative diseases. This biomedical potential is as great as, or greater than, the potential offered by human embryonic stem cell research. Simply stated, adult stem cell research is a preferable alternative for regenerative medicine and cell-based therapies because it does not pose the medical, legal, and ethical problems associated with human embryonic stem cell research.
dc.titleThe Case Against Federal Funding of Human Embryonic Stem Cell Research
dc.source.journaltitleYale Journal of Health Policy, Law, and Ethics
refterms.dateFOA2021-11-26T11:51:40Z
dc.identifier.legacycoverpagehttps://digitalcommons.law.yale.edu/yjhple/vol2/iss1/12
dc.identifier.legacyfulltexthttps://digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article=1039&context=yjhple&unstamped=1


Files in this item

Thumbnail
Name:
16_2YaleJHealthPolyL_Ethics201 ...
Size:
551.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record